(Q37256021)

19 August 2017

T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals (English)

1 reference

19 August 2017

1 reference

7

1 reference

Michael von Bergwelt-Baildon

19 August 2017

2

object named as

Michael von Bergwelt-Baildon

0 references

author name string

Martin R Weihrauch

1

1 reference

19 August 2017

Milos Kandic

3

1 reference

19 August 2017

Martin Weskott

4

1 reference

19 August 2017

Winfried Klamp

5

1 reference

19 August 2017

Joachim Rosler

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

World Journal of Gastroenterology

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

16

1 reference

19 August 2017

2529-2533

1 reference

A hepatitis B vaccine formulated with a novel adjuvant system

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Prevention and Therapy of Viral Hepatitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Vaccines to prevent viral hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Response to hepatitis B vaccine: multiple HLA genes are involved

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Intradermal vs intramuscular hepatitis B vaccinations

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708364

Defect in Th1-like cells of nonresponders to hepatitis B vaccine

3 December 2018

1 reference

12 December 2020

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

12 December 2020

Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen

1 reference

12 December 2020

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

12 December 2020

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

1 reference

12 December 2020

Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine

1 reference

12 December 2020

C4A deficiency and nonresponse to hepatitis B vaccination

1 reference

12 December 2020

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

12 December 2020

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection

1 reference

12 December 2020

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings

1 reference

12 December 2020

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

12 December 2020

Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients

1 reference

12 December 2020

HBsAg-induced interferon-gamma secretion in T cells from asymptomatic HBsAg carriers and HB-immune donors in vitro

1 reference

12 December 2020

HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells

1 reference

12 December 2020

There is No Correlation Between Function and Lymphokine Production of HBs-Antigen-Specific Human CD4+-Cloned T Cells

1 reference

12 December 2020

Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: a two-year follow-up

1 reference

12 December 2020

Normal HBsAg presentation and T-cell defect in the immune response of nonresponders

1 reference

12 December 2020

Global programme for control of hepatitis B infection

1 reference

12 December 2020

An effective intradermal hepatitis B vaccination

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.14.2529

1 reference

release_efcwyahjwfh4jnygprpsbyfy24

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/efcwyahjwfh4jnygprpsbyfy24

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

18442200

1 reference